---
figid: PMC3997714__OL-07-05-1345-g02
figtitle: Sorafenib activates autophagy through different signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3997714
filename: OL-07-05-1345-g02.jpg
figlink: /pmc/articles/PMC3997714/figure/f3-ol-07-05-1345/
number: F3
caption: Sorafenib activates autophagy through different signaling pathways. Autophagic
  cell death is triggered by sorafenib by suppressing myeloid cell leukemia-1 (Mcl-1)-related
  signaling pathway in hepatocarcinoma (HCC) PLC5, SK-Hep1, HepG2 and Hep3B cells
  (). Thus, inducers of autophagy may be used in combination with sorafenib to promote
  anti-cancer efficacy. Cytoprotective autophagy is triggered by sorafenib through
  endoplasmic reticulum (ER) or the Akt/mTOR signaling pathway in MHCC97-L and PLC/PRF/5
  cells (,). Inhibitors of autophagy may therefore be used in combination with sorafenib
  to promote anti-cancer efficacy.
papertitle: 'Autophagy: A novel therapeutic target for hepatocarcinoma (Review).'
reftext: ZHANGGUI WANG, et al. Oncol Lett. 2014 May;7(5):1345-1351.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9455324
figid_alias: PMC3997714__F3
figtype: Figure
redirect_from: /figures/PMC3997714__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3997714__OL-07-05-1345-g02.html
  '@type': Dataset
  description: Sorafenib activates autophagy through different signaling pathways.
    Autophagic cell death is triggered by sorafenib by suppressing myeloid cell leukemia-1
    (Mcl-1)-related signaling pathway in hepatocarcinoma (HCC) PLC5, SK-Hep1, HepG2
    and Hep3B cells (). Thus, inducers of autophagy may be used in combination with
    sorafenib to promote anti-cancer efficacy. Cytoprotective autophagy is triggered
    by sorafenib through endoplasmic reticulum (ER) or the Akt/mTOR signaling pathway
    in MHCC97-L and PLC/PRF/5 cells (,). Inhibitors of autophagy may therefore be
    used in combination with sorafenib to promote anti-cancer efficacy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - MCL1
  - ERN1
  - MTOR
  - BECN1
  - PIK3C3
---
